Introduction
In 2011, heterozygous mutations in the hematopoietic transcription factor GATA2 were identified as the cause of four previously described clinical syndromes: monocytopenia and mycobacterial infections (MonoMAC) syndrome;
1,2 dendritic cell, monocyte, B and NK lymphoid (DCML) deficiency; 3, 4 familial myelodysplastic syndromes (MDS)/acute myeloid leukemia (AML); 5 and Emberger syndrome (primary lymphedema with MDS). 6, 7 Interestingly, despite highly varied reasons for patient recruitment (disseminated mycobacterial infections, dendritic cell deficiency, familial MDS/AML, and primary lymphedema), there was considerable overlap among the clinical characteristics of all four cohorts. These syndromes are now recognized as different manifestations of a single genetic disorder with protean disease manifestations. More recently, GATA2 mutations have been identified in additional clinical cohorts including pediatric neutropenia, 8 aplastic anemia, 9 and the original case report of human NK cell deficiency. 10, 11 GATA2 mutations appear to cause loss of function of the mutated allele leading to haploinsufficiency. 12 Germline mutations appear to arise spontaneously but are then transmitted with autosomal dominant inheritance. 1, 2 The clinical hallmarks of GATA2 deficiency include immunodeficiency with marked susceptibility to human papillomaviruses (HPV) and nontuberculous mycobacteria (NTM), predisposition to MDS/AML, pulmonary alveolar proteinosis (PAP), and congenital lymphedema. The laboratory findings include severe circulating monocytopenia, dendritic cell cytopenia, and B and NK lymphocytopenia. These features overlap with other genetic and acquired syndromes. Mutations in TERT, TERC, CEBPA, and RUNX1 are also associated with familial MDS/AML. 13 Severe HPV infection is also characteristic of epidermodysplasia verruciformis, DOCK8 deficiency, CXCR4 deficiency,
For personal use only. on July 31, 2017. by guest www.bloodjournal.org From and idiopathic CD4 lymphocytopenia. 14 Inherited defects in the IL-12/IFN-γ axis as well as IFN-γ autoantibodies predispose to disseminated NTM infections. 15, 16 GM-CSF autoantibodies and mutations in the GM-CSF receptor may lead to PAP, 17 while FLT4 and other mutations may underlie congenital lymphedema.
18
There is considerable clinical heterogeneity among patients with GATA2 deficiency.
Age at disease onset ranges from early childhood to late adulthood and clinical presentations range from asymptomatic to life-threatening infections, leukemia, and respiratory failure. The genetic lesions in GATA2 are also heterogeneous, clustering into three different groups:
missense mutations and in-frame deletions involving the C-terminal zinc finger; nonsense mutations, frameshifts, and large gene deletions predicted to result in null alleles; and regulatory mutations within the enhancer region of intron 5. 2, 4, 5, 7, 8, 12, 19, 20 Genotype-phenotype correlations have been sought, but sample sizes and mutation distribution have been limiting. We report 57 patients with GATA2 deficiency in whom we performed comprehensive prospective characterization of the disease and looked for genotype-phenotype associations.
Methods

Subjects:
All patients or their guardians gave informed consent in accordance with the Declaration of Helsinki for Institutional Review Board-approved protocols at the National Institutes of Health (NIH) between January 1, 1992-March 1, 2013. Probands were recruited through natural history protocols for the study of NTM infection, primary immune deficiency, or inherited bone marrow failure syndromes. In patients with a positive family history, a reasonable effort was made to identify and screen all available blood relatives. The medical records of 57 patients with mutation-proven GATA2 deficiency were reviewed and extracted onto a
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Genotyping: Genomic DNA was isolated from peripheral blood, buccal swabs, or fibroblasts from all patients and available family members using Puregene DNA isolation kit (Qiagen). Amplification and sequencing of all exons, flanking splice sites, and regulatory regions was performed as previously described. 2, 12 Missense mutations were analyzed using PolyPhen2 to predict deleterious effects of amino acid changes. 21 Mutation groups were categorized as follows: "missense" includes all missense mutations and in-frame deletions in the C-terminal zinc finger predicted to allow production of a stable mRNA that is translated into a mutated protein; "null" includes nonsense and frameshift mutations and large gene deletions predicted to result in nonsense-mediated decay and no protein product; "regulatory" includes mutations in the enhancer region of intron 5 with demonstrated reduced expression of wild-type protein. 12, 20 A fourth mutation group designated "uniallelic" includes phenotypically GATA2 deficient individuals with reduced or absent expression from one GATA2 allele but without defined mutations. Lymphedema was considered in patients with chronic lower extremity and/or genital edema not attributable to other causes and severe enough to require treatment with compression stockings or lymphatic surgeries.
Statistical methods:
Fisher's exact test was used to detect associations between basic demographics and genotype. For time-to-event analyses, Kaplan-Meier curves were used to estimate survival; log rank tests and Cox regression, stratified on proband status and with robust variances, were used to detect associations between mutation groups. An exact log rank was used for one rare endpoint (lymphedema). Wald tests using robust variance estimates to account for within kindred correlation were used to evaluate mean differences between groups for continuous markers. Skewed laboratory markers were log-transformed, and counts were offset by half the lower limit of detection to avoid logarithms of zero. Statistical analyses were performed using R (Version 2.14.0. Vienna: R Development Core Team). P values (<0.05) were not adjusted for multiple comparisons.
Results
We identified 57 patients with GATA2 deficiency, 40 based on clinical presentation and 17 through family screening ( Table 1) . Fifty-four percent were female; 75% were Caucasian, 16% Hispanic, 7% African American, and 2% Asian (Table S1 ). Thirty-three mutations were characterized as missense, 12 null, 9 regulatory, and 3 uniallelic (Figure 1 ). There were no The proportion of patients without symptoms was 50% by age 20, 25% by age 30, and 16% by age 40 (Figure 2) . Survival declined soon after onset of symptoms, with 91% estimated survival by 5 years after onset, 84% by 10 years, and 67% by 20 years. Overall survival was 96% by age 20, 77% by age 40, and 45% by age 60. Twenty-one patients underwent allogeneic HSCT for MDS/AML, PAP, and/or recurrent infection (age at transplant 15-49 years). The proportion surviving without HSCT was 89% by age 20, 76% by age 30, and 53% by age 40.
Post-transplant survival was 72% by 1 year, 65% by 2 years, and 54% by 4 years after HSCT.
Clinical Features
Hematologic
Hemograms and lymphocyte phenotyping from initial NIH evaluation were available for 55 and 51 patients, respectively. B lymphocytopenia (86%), NK lymphocytopenia (82%), and monocytopenia (78%) were common and profound ( Figure S1 ). CD4 lymphocytopenia (51%)
For personal use only. on July 31, 2017. by guest www.bloodjournal.org From and neutropenia (47%) were also common but generally less marked. Pancytopenia was observed in the setting of MDS and monocytosis in patients with CMML. Of 50 patients who underwent bone marrow biopsies, 42 (84%) met diagnostic criteria for MDS with most marrows demonstrating multilineage dysplasia and <5% blasts (Table S2 ). In contrast to de novo MDS, which is typically characterized by marrow hypercellularity, most marrows were hypocellular for age with increased reticulin fibrosis ( Figure 3A) . 23 Atypical megakaryocytes were identified in 92%, even in those without overt MDS (Figure 3B-D) . 23, 24 Forty-eight percent had abnormal bone marrow cytogenetics, including trisomy 8 in 24% and monosomy 7 in 16%. Fourteen percent evolved into AML and 8% met criteria for CMML. Increased populations of CD3+CD8+CD56+ large granular lymphocytes were detected in 16%.
Infectious
Major infections afflicted 82% of patients (Table S3) . Severe viral infections were the most common (70%), particularly HPV (63%) presenting with recalcitrant warts, condylomata, and/or dysplasia. Severe herpesvirus infections were present in 35%: recurrent herpes stomatitis, esophagitis, or genital infection 16%; severe varicella 11%; persistent EBV viremia 11%; and cytomegalovirus pneumonia or disseminated disease 4%. Two patients developed severe cutaneous molluscum contagiosum infections. Disseminated NTM infections were present in 53% of patients, but this may reflect a referral bias of our institution (Figure 3E-F 
Pulmonary
Biopsy-proven PAP was identified in 10 adults (18%), all of whom lacked anti-GM-CSF autoantibodies and were refractory to subcutaneous and inhaled GM-CSF therapy ( Figure 3G- 
H). Five patients with PAP (9%) developed subsequent pulmonary arterial hypertension (PAH).
Following HSCT, all patients with PAP/PAH demonstrated significant improvement in pulmonary function including weaning from supplemental oxygen and medications for PAH. 25 Even among patients without PAP, pulmonary function and radiographic appearance were typically abnormal (Table S4) . Of 38 patients who received pulmonary function testing, 30 (79%) had diffusion defects and 24 (63%) had ventilatory defects, including obstruction (39%), restriction (11%), and mixed patterns (13%). Structural abnormalities identified on chest CT included nodules, reticular opacities, ground glass opacities, subpleural blebbing, "crazy paving", and paraseptal emphysema. Surprisingly, despite profound circulating monocytopenia, alveolar macrophages were abundant in bronchoalveolar lavage fluids.
Dermatologic
Dermatologic disease was often an indicator of underlying infection or malignancy (Table S5) . Recurrent warts were present in the majority of patients (53%) and were often the initial manifestation of disease. Common and flat warts were present on the extremities (39%) and/or genitalia (32%) (Figure 3I -J) and were typically refractory to cauterization, cryotherapy, topical imiquimod, 5-fluorouracil, corticosteroids, and laser therapies. Biopsy-proven panniculitis/erythema nodosum was seen in 30% and was commonly associated with underlying NTM or fungal infection ( Figure 3K ). Skin cancers, including basal cell carcinoma, squamous cell carcinoma (SCC), and malignant melanoma, developed in 6 patients (11%), half of whom had multiple cancers. Sweet's syndrome was seen in 3 patients in the setting of underlying MDS/AML.
Neoplastic
The majority of solid tumors were related to underlying viral infections. HPV-related dysplasia was observed in 35% and ranged from squamous intraepithelial lesions/Bowenoid papulosis to invasive SCC (Table S6) For personal use only. on July 31, 2017. by guest www.bloodjournal.org From developed breast cancers, one of whom had a BRCA2 mutation. Other solid tumors included adenocarcinoma of the pancreas, renal cell carcinoma, and a locally invasive desmoid tumor of the chest wall.
Cardiovascular & Lymphatic
Chronic lymphedema was present in 6 patients (11%) and could involve the unilateral or bilateral lower extremities and genitalia ( Figure 3N ). Severe cases developed in infancy or childhood, were complicated by recurrent cellulitis, and often required lymphatic surgeries.
Other cases only first manifested in adolescence or adulthood and were managed conservatively with compression stockings. Venous thromboses, including deep vein thrombosis, pulmonary embolism, portal vein thrombosis, and catheter-related thrombosis, were observed in 14 patients (25%), half of whom had multiple events (Table S7) 
Other Clinical Findings
Other associated clinical findings included sensorineural hearing loss, miscarriage, and idiopathic hypothyroidism. Of 25 patients with age-adjusted audiograms, 19 (76%) had mild to severe sensorineural hearing loss typically involving the high frequency range (Table S8) .
For personal use only. on July 31, 2017. by guest www.bloodjournal.org From However, prior aminoglycoside exposure for disseminated NTM infections may confound this relationship. Follow-up audiograms on 9 patients found 5 with progressive deterioration. Of 43 known pregnancies in our cohort, 14 (33%) resulted in miscarriage (Table S9) . Notably, all women who miscarried demonstrated marked NK lymphocytopenia. Idiopathic hypothyroidism requiring thyroid hormone replacement was observed in 14%.
Phenotype Clustering
Certain clinical phenotypes were frequently encountered in combination with others 
Phenotypic Variation Within Kindreds
Certain phenotypes tended to cluster within families ( Figure S3 ). For example, in kindred 40, the proband and his siblings each developed warts and MDS with trisomy 8. Their family history was also significant for multiple family members with MDS/AML and HPVrelated cancer. Interestingly, however, their father carries the exact same mutation but is 
Genotype-Phenotype Associations
We compared Kaplan-Meier disease-free survival curves among patients with missense, null, and regulatory mutations for the following endpoints: onset of illness, MDS/AML, severe viral infection, NTM/fungal infection, PAP, lymphedema, survival, and transplant-free survival (Figure 4) . Severe viral infections were more common and had earlier-onset in those with null mutations (p=0.038). Lymphedema was only observed in those with null or regulatory mutations, but not in those with missense mutations (exact log rank p=0.006). No other endpoints differed significantly among mutation groups.
For
Blood Counts and Disease Severity
We developed a scoring system to estimate disease severity or progression based on the number of major complications. The following were considered as major complications given their associated morbidity and mortality: MDS/AML, severe viral infection, NTM/fungal infection, and PAP. Initial presenting B cell, NK cell, monocyte, and CD4 T cell counts were compared among individuals with 0, 1, 2, 3 or 4 of these complications at the time of clinical presentation ( Figure 5 ). Among individuals with no major complications, median blood counts were within the normal range. However, as complications mounted, median blood counts declined significantly for all cell lines (p<0.001).
Discussion
We systematically reviewed 57 patients with GATA2 deficiency and identified a broad phenotype encompassing MDS/AML, immunodeficiency, pulmonary disease, vascular/lymphatic dysfunction, and additional clinical associations (Figure 6) 25 An association between PAP and hematologic malignancies has long been appreciated 17 ;
GATA2 deficiency unifies both entities and may help explain this association. Given the abundance of alveolar macrophages in lavage fluids from our patients, PAP in GATA2 deficiency must reflect alveolar macrophage dysfunction rather than a quantitative deficit.
Indeed GATA2 has been shown to regulate alveolar macrophage phagocytosis. 38 We identified PAH only in the setting of PAP, likely reflecting that progressive lung disease can drive arterial dysfunction. Patients with PAP who lack anti-GM-CSF autoantibodies should be screened for GATA2 mutations, particularly those with comorbid immunodeficiency and/or MDS/AML.
HSCT markedly improved pulmonary function in patients with PAP, presumably via reconstitution of the alveolar macrophage compartment. 25 The high prevalence of diffusion and ventilatory defects in our cohort may reflect alveolar filling, emphysematous changes, fibrosis, or bronchiectasis secondary to recurrent pulmonary infection. 
39,40
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20,41-43 Thrombotic events in one quarter of patients suggest an association between GATA2 deficiency and coagulopathy, more likely due to endothelial rather than coagulation abnormalities. In the lymphatic endothelium, GATA2 is involved in the development of lymphatic valves, deficiency of which likely underlies lymphedema. 19 Endocarditis may reflect GATA2 haploinsufficiency in the endocardium and/or impaired overlap with GATA4 function, which is involved in cardiogenesis. [44] [45] [46] Importantly, the development of thrombotic events and endocarditis in the early post-transplant period suggests that HSCT may not immediately ameliorate cardiovascular risks.
GATA2 is required for development of the semicircular canals and perilymphatic space of the vestibular system 47 , and its haploinsufficiency may lead to hearing loss. GATA2 also interacts with GATA3, haploinsufficiency of which is associated with congenital deafness. 48 Although hearing loss is confounded by aminoglycoside exposure in our cohort, it was also present in several patients without prior exposure. GATA2 deficient patients are likely more susceptible to ototoxic insults, which should inform the use of aminoglycosides in these patients.
The 33% prevalence of miscarriage in our cohort exceeds the 15-20% rate suspected in the general population. 49 Dysfunction of uterine NK cells, which regulate trophoblast invasion and uterine spiral artery angiogenesis, may be one potential mechanism. 50,51 GATA2 expression may also be impaired in trophoblast giant cells, which are critical for embryonic implantation and placental function. 52-54 Vascular dysfunction may also contribute to miscarriage.
Hypothyroidism affected 14%, which may reflect GATA2-mediated transcriptional activation of the thyrotropin beta gene. 55 However, thyroid dysfunction is relatively common and further studies are necessary to determine the mechanism of this association.
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The marked clinical heterogeneity of GATA2 deficiency is multifactorial. Severe viral infections and lymphedema were more common in individuals with null mutations, suggesting an effect of genotype on clinical phenotype. This may explain why the great majority of patients previously reported with Emberger syndrome have nonsense and frameshift mutations or large gene deletions predicted to result in null alleles. 7, 19 However, in our series, even among individuals within the same family there was considerable variation in clinical phenotype, largely negating a generalized genotype-phenotype association. Contiguous gene deletion syndromes may be a somewhat separate entity, as described. 19 The distinction between the roles of background genetics and environmental exposure will await work in animal models. Clearly environmental factors, such as exposure to endemic mycoses and mycobacteria, influence certain infections. ASXL1 is emerging as an important "second hit" associated with transformation from MDS to overt leukemia.
36,37
The clinical spectrum of our cohort is necessarily limited by the referral bias of our center. Many probands were recruited through natural history protocols for the study of NTM infections or primary immune deficiency. However, the addition of 17 relatives identified through family screening was an important opportunity to obtain a more complete picture of the clinical phenotype. Our cohort is also likely underrepresented for those with acute and fatal presentations, representing possible length bias and causing an optimistic bias in survival estimates. 56 These potential biases can only be addressed through broader testing for GATA2 mutations and prospective study in additional cohorts.
Our pathophysiologic understanding of GATA2 deficiency is primitive but rapidly growing. GATA2 interacts closely with GATA1 in the development of the hematopoietic compartment and GATA3 in trophoblastic development. 26 It underlies the development of
For personal use only. on July 31, 2017. by guest www.bloodjournal.org From circulating myeloid dendritic cells but seems to permit infections or cancer only after a prolonged latency. 57 Finally, while haploinsufficiency is clearly pathologic and leads to myeloid leukemia in a substantial number of cases, gain of function mutations are also associated with myeloid leukemias, indicating that the proper regulation of GATA2 is both critical and its range quite narrow. 58 It is now clear that GATA2 deficiency is a protean disorder that unites susceptibility to immunodeficiency, bone marrow failure, pulmonary disease and vascular/lymphatic dysfunction. It causes cases of familial and sporadic MDS/AML, aplastic anemia, neutropenia, primary immune deficiency, and lymphedema, the full extent of which is yet to be determined. Early genetic diagnosis is essential for appropriate disease management, prophylaxis, transplantation, and family screening. 
